Sonepcizumab
Product Specifications
CAS Number
1031360-18-5
Target
LPL Receptor
Related Pathways
GPCR/G Protein
Purity
0.989
Bioactivity
Sonepcizumab (LT 1009) is a fully humanized monoclonal antibody against S1P, with anti-cancer activity, useful for studying metastatic renal cell carcinoma (mRCC) and preventing eye scarring after glaucoma filtration surgery.
Shipping Conditions
Ice Packs
Storage Temperature
-20°C
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1331474-01 0.02 mg (E-Coli)
Recombinant Neisseria meningitidis serogroup B Ribonuclease P protein component (rnpA)
Sign In for Pricing
View Details MBS1331474-02 0.1 mg (E-Coli)
Recombinant Neisseria meningitidis serogroup B Ribonuclease P protein component (rnpA)
Sign In for Pricing
View Details MBS1331474-03 0.02 mg (Yeast)
Recombinant Neisseria meningitidis serogroup B Ribonuclease P protein component (rnpA)
Sign In for Pricing
View Details MBS1331474-04 0.1 mg (Yeast)
Recombinant Neisseria meningitidis serogroup B Ribonuclease P protein component (rnpA)
Sign In for Pricing
View Details MBS1331474-05 0.02 mg (Baculovirus)
Recombinant Neisseria meningitidis serogroup B Ribonuclease P protein component (rnpA)
Sign In for Pricing
View Details